Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-120752

Director acquired 139 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Drutz David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-18 Exercise or conversion : show line 1 in the form +139 $2.40 $334 20,151 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-18 Exercise or conversion : show line 2 in the form Stock Options (option to buy) −139 0 D
Loading xslF345X03/tm2231089-1_4seq1.xml…